'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.

ABSTRACT:

Background

The advent of direct-acting antivirals (DAAs)-a form of hepatitis C (HCV) treatment associated with shorter treatment course and greater efficacy-offers an unprecedented opportunity to eliminate HCV, but only if care delivery systems are developed to extend treatment to people who inject drugs (PWID). To support the design of a community-pharmacy program, we explored perspectives of PWID with chronic HCV with regard to barriers, motivators, preferences, and prior experiences related to HCV treatment and pharmacists.

Methods

We conducted semi-structured interviews with people living with HCV who reported active injection drug use. Participants were recruited from local community service and clinical organizations in the Seattle, Washington region, and focus groups

SUBMITTER: Tsui JI 

PROVIDER: S-EPMC8358259 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature